These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 367433)

  • 1. Ocular and cardiovascular effects of local and systemic pindolol.
    Smith SE; Smith SA; Reynolds F; Whitmarsh VB
    Br J Ophthalmol; 1979 Jan; 63(1):63-6. PubMed ID: 367433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local and systemic effects of pindolol eye drops.
    Mekki QA; Penhall R; Edgar DF; Stewart-Jones JH; Turner P
    Br J Clin Pharmacol; 1983 Jan; 15(1):112-3. PubMed ID: 6849733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pindolol eye drops (Glauco-Visken) - half year's results in glaucoma therapy].
    Merté HJ; Stryz JR; Mertz M
    Klin Monbl Augenheilkd; 1984 Mar; 184(3):227-32. PubMed ID: 6374263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is pindolol suitable for the therapy of glaucoma? Evaluation of the dose-effect of various concentrations of pindolol eyedrops].
    Dausch D; Görlich W; Honegger H
    Klin Monbl Augenheilkd; 1984 Jun; 184(6):536-8. PubMed ID: 6384636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 0.25% and 0.5% pindolol in intraocular pressure in normal human volunteers.
    Tyas C; Stewart-Jones JH; Edgar DF; Turner P
    Curr Med Res Opin; 1981; 7(8):550-2. PubMed ID: 7307546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopharmacological studies with pindolol following intravenous and oral administration].
    Aellig WH
    Adv Clin Pharmacol; 1976; 11():9-13. PubMed ID: 1032575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pindolol on intraocular pressure in glaucoma: pilot study and a randomised comparison with timolol.
    Andréasson S; Jensen KM
    Br J Ophthalmol; 1983 Apr; 67(4):228-30. PubMed ID: 6338906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ; Smith SE
    Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pindolol on intraocular pressure.
    Bonomi I; Steindler P
    Br J Ophthalmol; 1975 Jun; 59(6):301-3. PubMed ID: 1100097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical suitability of pindolol eyedrops in the treatment of chronic open-angle glaucoma].
    Dausch D; Görlich W; Honegger H
    Klin Monbl Augenheilkd; 1984 Jun; 184(6):539-42. PubMed ID: 6384637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A noninvasive tonometer in the measurement of the effects of pindolol and timolol on intraocular pressure in normal subjects.
    Rowley S; Staunton JE; Tosch A; Stewart-Jones JH; Edgar DF; Turner P
    Br J Ophthalmol; 1981 Aug; 65(8):536-8. PubMed ID: 7295615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metoprolol eye drops in the treatment of glaucoma. A double-blind single-dose trial of a beta1-adrenergic blocking drug.
    Ros FE; Dake CL; Nagelkerke NJ; Greve EL
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Jun; 206(4):247-54. PubMed ID: 356658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of pindolol to routine medical therapy: a clinical trial.
    Smith RJ; Blamires T; Nagasubramanian S; Watkins R; Poinoosawmy D
    Br J Ophthalmol; 1982 Feb; 66(2):102-8. PubMed ID: 7037046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular responses in healthy subjects to topical bunazosin 0.3%--an alpha 1-adrenoceptor antagonist.
    Trew DR; Wright LA; Smith SE
    Br J Ophthalmol; 1991 Jul; 75(7):411-3. PubMed ID: 1677267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of various beta blockers on intraocular pressure and ventilation].
    Bleckmann H; Dorow P
    Fortschr Ophthalmol; 1986; 83(5):567-9. PubMed ID: 2878863
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications and contraindications of beta blockaders in the treatment of glaucoma].
    Bleckmann H; Dorow P
    Dtsch Med Wochenschr; 1984 Feb; 109(5):180-3. PubMed ID: 6141926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
    Aellig WH; Narjes HH; Nüesch E; Oertle RJ; Devos JE; Pacha W
    Eur J Clin Pharmacol; 1981; 20(3):179-83. PubMed ID: 7286035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The local anesthetic effect and subjective tolerance of 0.5% befunolol and 1% pindolol in healthy eyes].
    Höh H
    Klin Monbl Augenheilkd; 1990 Apr; 196(4):219-24. PubMed ID: 1971855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific hypotensive and antihypertensive ocular effects of d-isoproterenol in rabbits.
    Seidehamel RJ; Dungan KW; Hickey TE
    Am J Ophthalmol; 1975 Jun; 79(6):1018-25. PubMed ID: 1136990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.